Impact of obesity on female sexual dysfunction: A remiss

2020 ◽  
Vol 16 ◽  
Author(s):  
Asma Farooq Shah ◽  
Isha Chawla ◽  
Kirti Goel ◽  
Rakesh Gollen ◽  
Randhir Singh
Keyword(s):  
Sexual Dysfunction ◽  
Female Sexual Dysfunction ◽  
Kidney Diseases ◽  
Public Health Problem ◽  
Point Of View ◽  
Sexual Disorders ◽  
Sexual Dysfunctions ◽  
Obese Women ◽  
Prevalence Of Obesity ◽  
The Impact

: The prevalence of obesity around the globe is increasing at such an alarming rate that WHO consultation on obesity designated obesity as a major unattended public health problem worldwide. Obesity is associated with a greater risk of excessive fat related metabolic and endocrinal diseases associated with different set of illness and disabilities, including type 2 diabetes, cardiovascular diseases, kidney diseases, sleep apnea, arthritis, lung diseases and sexual disorders. Obesity is found to be associated with male and female sexual dysfunctions and several studies have indicated a positive correlation between obesity and sexual dysfunction among both males and females. The relationship between male obesity and sexual dysfunction has been widely discussed, whereas a very little emphasis is laid on relationship between obesity and female sexual dysfunctions. Sexual dysfunctions are common and affects 20-50% of obese women. Particularly, female sexual dysfunction is a multi-factorial problem, including organic and psychological aspects involved into it. These disorders not only affect physical health of women but to a greater extent mental health is also affected. Considering this point of view, present review is emphasized on the impact of obesity on female sexual dysfunctions.

Female sexual dysfunction: a problem hidden in the shadows

2021 ◽  
Vol 27 ◽  
Author(s):  
Konstantinos P. Imprialos ◽  
Konstantinos Koutsampasopoulos ◽  
Aleksandra Katsimardou ◽  
Sofia Bouloukou ◽  
Iakovos Theodoulidis ◽  
...  
Keyword(s):  
Risk Factors ◽  
Sexual Dysfunction ◽  
Female Sexual Dysfunction ◽  
Treatment Options ◽  
Public Health Problem ◽  
Management Options ◽  
Significant Public Health Problem ◽  
Significant Public Health ◽  
Cv Disease

Background: Female sexual dysfunction (FSD) has mainly been underdiagnosed and undertreated due to the lack of concrete definitions, validated assessment methods, and efficient treatments. However, during the last few decades, there has been significant progress in the clinical management and research of FSD. Objective: The purpose of this review is to describe the pathophysiology of FSD, report the prevalence of the disease in the setting of cardiovascular (CV) risk factors and disease, and review current and under investigation treatment options. Methods: A comprehensive literature review was performed to identify studies examining the association of FSD with CV risk factors and/or disease and studies reporting appropriate management options. Results: The prevalence of FSD is increased in the general population (approximately 40%) and is significantly higher in patients with hypertension, diabetes mellitus, and dyslipidemia. In patients with overt CV disease, FSD is even more prevalent (up to 90%). The cause of FSD is multifactorial and includes various vascular, hormonal, interpersonal, and psychological factors, which are all intertwined. Several treatment options exist that are efficient in improving female sexual function, while a cluster of other alternatives has been shown to offer benefits. Conclusion: FSD is a significant public health problem with a great impact on the patients’ quality of life. In the setting of increased CV burden, FSD is even more prevalent. Increased awareness is needed for the physician to establish a trustful environment with the patient, discuss such issues, and offer suitable management options.

scholarly journals The Impact of Metabolic Syndrome and Its Components on Female Sexual Dysfunction: A Narrative Mini-Review

2018 ◽  
Vol 12 (2) ◽  
pp. 57-63
Author(s):  
Simona Di Francesco ◽  
Marika Caruso ◽  
Iole Robuffo ◽  
Andrea Militello ◽  
Elena Toniato
Keyword(s):  
Diabetes Mellitus ◽  
Metabolic Syndrome ◽  
Sexual Dysfunction ◽  
Arterial Hypertension ◽  
Sexual Function ◽  
Sexual Desire ◽  
Female Sexual Dysfunction ◽  
Systemic Arterial Hypertension ◽  
The Metabolic Syndrome ◽  
The Impact

Background: The impact of metabolic syndrome on female sexual dysfunction received modest consideration in clinical practice. The aim of the research was to analyze the international literature to determine the relationship between the metabolic syndrome, its components and female sexual disorders. Methods: We identified relevant full-length papers by electronic databases as Index Medicus/Medline, Scopus, Life Science Journals, from 2005 to the present. Studies were searched using the following as search query: metabolic syndrome, female sexual dysfunction, obesity, systemic arterial hypertension, diabetes mellitus, dyslipidemia. Results: Women with metabolic syndrome showed higher prevalence of sexual inactivity and low sexual desire, orgasm and satisfaction respect to women without metabolic syndrome. Particularly metabolic components as diabetes mellitus, dy-slipidemia, systemic arterial hypertension were strongly associated with lower sexual desire, activity and Female Sexual Function Index total score. In contrast, other studies showed no relationship. Conclusion: Our study showed that in the clinical evaluation of women with metabolic syndrome routine inquiring about female sexual dysfunction should be recommended to ameliorate sexual function and quality of life. However more prospective and longitudinal studies on the sexual effects of metabolic syndrome should also be suggested to know the factors related to women's sexuality better.

Sexual Dysfunction in Patients with Neuropsychiatric Disorders: Challenges and Opportunities

CNS Spectrums ◽  
2006 ◽  
Vol 11 (S9) ◽  
pp. 4-4
Author(s):  
Barry Gidal ◽  
John J. Barry
Keyword(s):  
Quality Of Life ◽  
Sexual Dysfunction ◽  
Adverse Effects ◽  
Sexual Function ◽  
Healthcare Providers ◽  
Well Being ◽  
Sexual Disorders ◽  
Functional Impairments ◽  
The Impact

Quality-of-life issues in healthcare have come to be of paramount importance for a population that increasingly expects healthcare not only to treat major illnesses but also to optimize normal levels of physical and psychosocial functioning and overall well-being. Healthcare providers have also increasingly appreciated the impact that adverse effects of treatment can have on quality of life, as well as on compliance with and the effectiveness of treatment.Many functional impairments and adverse treatment effects take the form of clinical complaints that patients and caregivers typically report to their healthcare providers without prompting. Other adverse effects are not so obviously clinical or treatment-related, and patients may not be inclined or may even be reluctant to bring them up when talking with the provider. Impairment of sexual function is a problem of this kind.Sexual dysfunction appears to be common and frequently underrecognized in certain patient populations. For example, it has been estimated that 25% to 63% of women and 10% to 52% of men with epilepsy have some form of sexual dysfunction, yet in clinical reviews of sexual disorders, epilepsy is not listed as one of the medical conditions commonly associated with impaired sexual function.

scholarly journals The impact of systemic lupus erythematosus on female sexual dysfunction in china

2020 ◽  
Vol 4 (1) ◽  
Author(s):  
Ying-Hua Pan ◽  
Zhan-Qin Shao ◽  
Yu-Hua Deng ◽  
Lei He ◽  
Heng-Ying Fang ◽  
...  
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Sexual Dysfunction ◽  
Lupus Erythematosus ◽  
Female Sexual Dysfunction ◽  
Systemic Lupus ◽  
The Impact

The New Avatar of Female Sexual Dysfunction in ICD-11—Will It Herald a Better Future?

2019 ◽  
Vol 1 (2) ◽  
pp. 111-113
Author(s):  
Soumya Parameshwaran ◽  
Prabha S. Chandra
Keyword(s):  
Clinical Practice ◽  
Sexual Dysfunction ◽  
Sexual Health ◽  
Female Sexual Dysfunction ◽  
Sexual Problems ◽  
Sexual Dysfunctions ◽  
Diagnosis And Management

Female sexual dysfunction has always had challenges related to nosological issues due to inadequate research and understanding in this area. The ICD-11 has proposed substantial changes to the classification of conditions related to sexual health. In this review, we have discussed the proposed changes, compared with other classificatory systems and discussed its implications on clinical practice and research in this field. While there have been several progressive moves in the taxonomy of sexual dysfunctions, we have expressed our views on possible changes which can help with better diagnosis and management of sexual problems in women.

scholarly journals Female sexual dysfunction among overweight and obese women in Kota Bharu, Malaysia

2016 ◽  
Vol 11 (2) ◽  
pp. 159-167 ◽  
Author(s):  
Artini Abidin ◽  
Nani Draman ◽  
Shaiful B. Ismail ◽  
Izadora Mustaffa ◽  
Imran Ahmad
Keyword(s):  
Sexual Dysfunction ◽  
Female Sexual Dysfunction ◽  
Obese Women

scholarly journals A study of sexual dysfunction and its associated factors among women in childbearing age, Egypt

2018 ◽  
Vol 9 (3) ◽  
pp. 95 ◽  
Author(s):  
Mirfat Mohamed Labib El-Kashif ◽  
Sheren Ebrahim El-tahry
Keyword(s):  
Sexual Dysfunction ◽  
Associated Factors ◽  
Female Sexual Dysfunction ◽  
Public Health Problem ◽  
Population Based ◽  
Childbearing Age ◽  
Cross Sectional Survey ◽  
Cross Sectional ◽  
Arousal Disorder ◽  
Low Educated

Background and objective: Sexual dysfunction is a significant public health problem that is more common among women than in men. The women sexual dysfunction and the factors influencing it have not yet been fully investigated. Aim: The present study aimed to evaluate sexual dysfunction and its associated factors among women in childbearing age, Egypt.Methods: A population-based cross-sectional survey involving 780 non-pregnant sexual active females aged 15-51 years old who were recruited into the study by random sampling. The study population was selected from health facilities which affiliated to the ministry of health in Damietta Governorate. Interview tools used to collect data related to female and male partner.Results: A total of 780 women in childbearing age were enrolled. More than half of the studied women have sexual dysfunction versus 46.9% without sexual function. 22.3% of sexual dysfunction women have mild dysfunction, 18.5% of them have moderate dysfunction, and 12.3% have severe dysfunction. Desire disorder was the most common sexual disorder among participants (67.3%), followed by arousal disorder (55.8%). There was a statistically significant correlation between female sexual dysfunction and husband's age, educational level and husbands suffer from depression, heavy smokers and hypnotic drugs used. Female sexual dysfunction was found among older age, low educated and non-workers females, as well as women, suffer chronic disease, genital inflammation, and stress.Conclusions: Sexual dysfunction is prevalent among women, so further study based on a comprehensive survey is necessarily needed.

Diagnosis and Assessment of Female sexual Dysfunction(s)

2009 ◽  
Vol 24 (S1) ◽  
pp. 1-1
Author(s):  
R. Balon
Keyword(s):  
Sexual Dysfunction ◽  
Sexual Desire ◽  
Sexual Functioning ◽  
Female Sexual Dysfunction ◽  
Clinical Interview ◽  
Sexual Dysfunctions ◽  
Sexual Distress ◽  
Gynecological Examination ◽  
Female Sexual Functioning ◽  
Distress Scale

The first challenge in diagnosing female sexual dysfunction(s) originates in our diagnostic system. The traditional model of classifying sexual dysfunction is anchored in the sexual response cycle: desire - arousal - orgasm - resolution. However, as some experts have pointed out, this classification may be problematic in the area of female sexuality. Both the diagnoses of female hypoactive sexual desire disorder (FHSDD) and female arousal disorder (FSAD) probably need to be redefined and refined. Examples include adding the lack of responsive desire to the FHSDD criteria and creating categories of subjective FSAD and genital FSAD.The second challenge in diagnosis female dysfunction is the lack of solid diagnostic instruments, diagnosis-specific laboratory assays and other specific testing. Specific measures of female sexual functioning, such as Female Sexual Functioning Index, Profile of Female Sexual Functioning, Sexual Function Questionnaire, Sexual Desire and Interest Inventory, and Female Sexual Distress Scale were mostly developed as outcome measures. No solid diagnostic instrument for sexual dysfunction exists, not even a version of the Structured Clinical Interview for DSM sexual dysfunctions. The contribution of imaging techniques, such as ultrasonography, magnetic resonance imaging or thermography, to the diagnosis is unclear, and these techniques are far (if ever) from clinical use.Thus, a detailed comprehensive clinical interview combined with physical examination, possibly a gynecological examination, and in some cases laboratory hormonal testing remains the cornerstone of diagnosing and assessing female sexual dysfunctions.

Sign in / Sign up

Export Citation Format

Share Document